Literature DB >> 22674451

[Potentially inappropriate medication: the quality of pharmacotherapy in the elderly].

U Thiem1.   

Abstract

Potentially inappropriate medication (PIM) in the elderly is a common problem in primary care. Depending on the setting under investigation, recent studies reported a prevalence of PIM up to 24% in Germany. In 2010 the German national PRISCUS list containing explicit criteria to identify PIM was published. First data show a possible association between PIM as defined by the Priscus list and negative health outcomes. However, prospective controlled trials are needed to assess whether interventions based on explicit criteria are able to improve patient-related outcome. Against this backdrop, the present review comments on recent data, especially those with impact for the German health care system.

Entities:  

Mesh：

Year:  2012        PMID： 22674451     DOI： 10.1007/s00108-012-3087-5

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN： 0020-9554            Impact factor:   0.743


  21 in total

1.  Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts.

Authors:  Donna M Fick; James W Cooper; William E Wade; Jennifer L Waller; J Ross Maclean; Mark H Beers
Journal:  Arch Intern Med       Date:  2003 Dec 8-22

2.  [Potentially inappropriate medication for the elderly: adaptation and evaluation of a French consensus list].

Authors:  Marita Kölzsch; Juliane Bolbrinker; Matthias Huber; Reinhold Kreutz
Journal:  Med Monatsschr Pharm       Date:  2010-08

Review 3.  Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine.

Authors:  M H Beers; J G Ouslander; I Rollingher; D B Reuben; J Brooks; J C Beck
Journal:  Arch Intern Med       Date:  1991-09

4.  Potentially inappropriate medications in geriatric outpatients with polypharmacy: application of six sets of published explicit criteria.

Authors:  Chirn-Bin Chang; Jen-Hau Chen; Chiung-Jung Wen; Hsu-Ko Kuo; I-Shu Lu; Lee-Shu Chiu; Shwu-Chong Wu; Ding-Cheng Derrick Chan
Journal:  Br J Clin Pharmacol       Date:  2011-09       Impact factor: 4.335

5.  Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START criteria.

Authors:  P F Gallagher; M N O'Connor; D O'Mahony
Journal:  Clin Pharmacol Ther       Date:  2011-04-20       Impact factor: 6.875

Review 6.  Comparison of prescribing criteria to evaluate the appropriateness of drug treatment in individuals aged 65 and older: a systematic review.

Authors:  Maarit S Dimitrow; Marja S A Airaksinen; Sirkka-Liisa Kivelä; Alan Lyles; Saija N S Leikola
Journal:  J Am Geriatr Soc       Date:  2011-07-28       Impact factor: 5.562

7.  Frequency of inappropriate drugs in primary care: analysis of a sample of immobile patients who received periodic home visits.

Authors:  Thomas Fiss; Adina Dreier; Claudia Meinke; Neeltje van den Berg; Christoph Alexander Ritter; Wolfgang Hoffmann
Journal:  Age Ageing       Date:  2010-09-07       Impact factor: 10.668

8.  Potentially inappropriate medications in the elderly: the PRISCUS list.

Authors:  Stefanie Holt; Sven Schmiedl; Petra A Thürmann
Journal:  Dtsch Arztebl Int       Date:  2010-08-09       Impact factor: 5.594

9.  STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation.

Authors:  P Gallagher; C Ryan; S Byrne; J Kennedy; D O'Mahony
Journal:  Int J Clin Pharmacol Ther       Date:  2008-02       Impact factor: 1.366

10.  The Norwegian General Practice (NORGEP) criteria for assessing potentially inappropriate prescriptions to elderly patients. A modified Delphi study.

Authors:  Sture Rognstad; Mette Brekke; Arne Fetveit; Olav Spigset; Torgeir Bruun Wyller; Jørund Straand
Journal:  Scand J Prim Health Care       Date:  2009       Impact factor: 2.581
View more
  3 in total

Review 1.  Low intensity transcranial electric stimulation: Safety, ethical, legal regulatory and application guidelines.

Authors:  A Antal; I Alekseichuk; M Bikson; J Brockmöller; A R Brunoni; R Chen; L G Cohen; G Dowthwaite; J Ellrich; A Flöel; F Fregni; M S George; R Hamilton; J Haueisen; C S Herrmann; F C Hummel; J P Lefaucheur; D Liebetanz; C K Loo; C D McCaig; C Miniussi; P C Miranda; V Moliadze; M A Nitsche; R Nowak; F Padberg; A Pascual-Leone; W Poppendieck; A Priori; S Rossi; P M Rossini; J Rothwell; M A Rueger; G Ruffini; K Schellhorn; H R Siebner; Y Ugawa; A Wexler; U Ziemann; M Hallett; W Paulus
Journal:  Clin Neurophysiol       Date:  2017-06-19       Impact factor: 3.708

2.  The impact of physician-level drug budgets on prescribing behavior.

Authors:  Katharina Elisabeth Fischer; Taika Koch; Karel Kostev; Tom Stargardt
Journal:  Eur J Health Econ       Date:  2017-02-13

3.  Side effects related to potentially inappropriate medications in elderly psychiatric patients under everyday pharmacotherapy.

Authors:  Gudrun Hefner; Viktoria Stieffenhofer; Susanne Gabriel; Gerlind Palmer; Kay-Maria Müller; Joachim Röschke; Christoph Hiemke
Journal:  Eur J Clin Pharmacol       Date:  2014-12-23       Impact factor: 2.953
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.